The partnership will allow Canada’s CRO to leverage cutting-edge technology provided by the European HealthTech company, in order to innovate and optimize preclinical studies CANADA & EUROPE — Canadian CRO… Read More
VANCOUVER, B.C. – Virogin Biotech, a clinical-stage biotech company is pleased to announce that their Investigational New Drug (IND) application for VG161 has been granted by the U.S. Food and… Read More
VivaZome Therapeutics wins top prize with its potential to provide off-the-shelf regenerative medicines. Part of Cytiva’s BioChallenge global series, the inaugural challenge for the Australia and New Zealand region received… Read More
VANCOUVER, B.C. — Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced the closing of its previously announced underwritten public offering of 11,035,000 common shares, including the… Read More
VANCOUVER, B.C. — Acuitas Therapeutics is excited to announce that it has entered into a sponsorship agreement with the 2022 Greater Vancouver Regional Science Fair (GVRSF). This is a partner-level… Read More
